Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$1.41B |
| 2 |
SBA Communications
SBAC
|
+$1.29B |
| 3 |
Avantor
AVTR
|
+$691M |
| 4 |
Celanese
CE
|
+$655M |
| 5 |
Fortive
FTV
|
+$592M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.19B |
| 2 |
Truist Financial
TFC
|
+$1.15B |
| 3 |
Wells Fargo
WFC
|
+$1.13B |
| 4 |
Bank of America
BAC
|
+$974M |
| 5 |
Goldman Sachs
GS
|
+$842M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.28% |
| 2 | Financials | 18.77% |
| 3 | Industrials | 12.45% |
| 4 | Technology | 12.31% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
DELISTED
Juniper Networks
JNPR
| $7.03M | ﹤0.01% |
187,600
-13,321,638
| -99% | -$504M |
2014 Q4
40 quarters
|
|
127
National Energy Services Reunited Corp
NESR
$1.97B
| $6.88M | ﹤0.01% |
+768,089
| New | +$6.79M |
2024 Q4
0 quarters
|
|
128
Analog Devices
ADI
$196B
| $6.63M | ﹤0.01% |
31,185
-630
| -2% | -$139K |
2021 Q3
13 quarters
|
|
129
Vulcan Materials
VMC
$31.3B
| $6.3M | ﹤0.01% |
24,500
-200
| -0.8% | -$53.8K |
2013 Q2
46 quarters
|
|
130
DELISTED
Hess
HES
| $6.11M | ﹤0.01% |
45,950
-600
| -1% | -$83.8K |
2019 Q2
22 quarters
|
|
131
Apple
AAPL
$5.01T
| $5.98M | ﹤0.01% |
23,868
| – | – |
2013 Q2
46 quarters
|
|
132
Berkshire Hathaway Class B
BRK.B
$1.13T
| $5.76M | ﹤0.01% |
12,703
| – | – |
2013 Q2
46 quarters
|
|
133
Synopsys
SNPS
$92B
| $5.51M | ﹤0.01% |
11,350
| – | – |
2013 Q2
46 quarters
|
|
134
Broadcom
AVGO
$1.65T
| $5.44M | ﹤0.01% |
23,460
-11,880
| -34% | -$2.2M |
2023 Q4
4 quarters
|
|
135
Deere & Co
DE
$175B
| $5.41M | ﹤0.01% |
12,761
-275
| -2% | -$116K |
2013 Q2
46 quarters
|
|
136
Motorola Solutions
MSI
$74.8B
| $3.99M | ﹤0.01% |
8,627
| – | – |
2013 Q2
46 quarters
|
|
137
Danaher
DHR
$158B
| $3.79M | ﹤0.01% |
16,525
| – | – |
2014 Q3
41 quarters
|
|
138
Amgen
AMGN
$230B
| $3.72M | ﹤0.01% |
14,282
| – | – |
2013 Q2
46 quarters
|
|
139
Shell
SHEL
$295B
| $3.61M | ﹤0.01% |
57,613
| – | – |
2022 Q1
11 quarters
|
|
140
iShares Russell 1000 Value ETF
IWD
$83.1B
| $3.17M | ﹤0.01% |
+17,100
| New | +$3.28M |
2024 Q4
0 quarters
|
|
141
Johnson & Johnson
JNJ
$612B
| $3.05M | ﹤0.01% |
21,097
| – | – |
2013 Q2
46 quarters
|
|
142
Pfizer
PFE
$166B
| $2.96M | ﹤0.01% |
111,560
-1,225
| -1% | -$33.2K |
2013 Q2
46 quarters
|
|
143
Dell
DELL
$323B
| $2.91M | ﹤0.01% |
25,265
-7,295
| -22% | -$915K |
2016 Q3
33 quarters
|
|
144
Hewlett Packard
HPE
$83.8B
| $2.9M | ﹤0.01% |
135,675
-56,108
| -29% | -$1.18M |
2015 Q4
36 quarters
|
|
145
PNC Financial Services
PNC
$86.1B
| $2.75M | ﹤0.01% |
14,275
| – | – |
2013 Q2
46 quarters
|
|
146
Berkshire Hathaway Class A
BRK.A
$1.13T
| $2.72M | ﹤0.01% |
4
| – | – |
2013 Q2
46 quarters
|
|
147
S&P Global
SPGI
$120B
| $2.69M | ﹤0.01% |
5,400
| – | – |
2016 Q2
34 quarters
|
|
|
148
Truist Financial
TFC
$55.7B
| $2.44M | ﹤0.01% |
56,346
-25,693,714
| -100% | -$1.15B |
2013 Q2
46 quarters
|
|
149
Halliburton
HAL
$27.4B
| $2.19M | ﹤0.01% |
80,660
-500
| -0.6% | -$14.6K |
2013 Q2
46 quarters
|
|
150
Philip Morris
PM
$320B
| $2.05M | ﹤0.01% |
17,000
| – | – |
2013 Q2
46 quarters
|
|
Similar funds
Dodge & Cox's Q4 2024 Portfolio in Review
As of Q4 2024, Dodge & Cox held 216 positions worth $172B, down 2.8% from $177B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Dodge & Cox's Q4 2024 filing shows 11 new, 45 increased, 101 reduced and 2 closed positions. Its largest new stake was Fortive: 10,323,937 shares worth $583M. The largest sale was Alphabet (Google) Class C, an estimated $1.19B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dodge & Cox's largest Q4 2024 buy was Fortive: 10,323,937 shares worth $583M.
- Dodge & Cox added most to Humana in Q4 2024, an estimated $1.41B increase.
- Dodge & Cox's biggest Q4 2024 reduction was Alphabet (Google) Class C, cutting an estimated $1.19B.
- Dodge & Cox fully exited KE Holdings in Q4 2024, selling an estimated $367K.
- Dodge & Cox's ten largest holdings make up 29% of its $172B portfolio in Q4 2024.
- Dodge & Cox opened 11 new positions and closed 2 in Q4 2024.
- Dodge & Cox's portfolio value fell 2.8% quarter-over-quarter to $172B.
Based on Dodge & Cox's 13F filing for Q4 2024, filed 13 Feb 2025.